Metformin for Improving Blood Vessel Function After Gestational Diabetes
Metformin for the Treatment of Microvascular Dysfunction After Gestational Diabetes
- Age
- 18 – 45
- Sex
- Female
- Trial phase
- Early Phase 1
- Study type
- Interventional
- Purpose
- Basic Science
- Participants needed
- 30 (estimated)
- Sponsor
- Anna Stanhewicz, PhD · Other
This trial is looking for women who have had gestational diabetes and are at least 12 weeks postpartum. Participants will be given metformin to see if it helps improve blood vessel function in these women.
You may be able to join if
- I am at least 12 weeks postpartum
- I had gestational diabetes
- I had a healthy pregnancy
You may not be able to join if
- I have been diagnosed with prediabetes or diabetes
- I currently use tobacco
- I have cardiovascular or metabolic disease
- I take medication for cardiovascular or metabolic disease
- I had high blood pressure during pregnancy
- I am currently pregnant
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your EligibilityThe purpose of this investigation is to examine the mechanisms mediating vascular dysfunction in women who have had gestational diabetes and how metformin may be a valuable treatment tool to improve microvascular function in these women before the onset of disease.
Loading trial locations…